Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
Clinical and Molecular Hepatology
; : 82-86, 2013.
Article
em En
| WPRIM
| ID: wpr-176452
Biblioteca responsável:
WPRO
ABSTRACT
Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine has a more potent and sustained antiviral activity with a lower frequency of viral resistance than lamivudine. Although there are several reports concerning the safety profile of telbivudine, most adverse events are described as mild and transient in nature. Here we report two cases of telbivudine-induced myopathy in patients with chronic hepatitis B who were siblings.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Antivirais
/
Timidina
/
Músculo Esquelético
/
Hepatite B Crônica
/
Creatina Quinase
/
Irmãos
/
Eletromiografia
/
Doenças Musculares
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article